Cyclophosphamide/daratumumabFebrile neutropenia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1970卷 / 1期

关键词：

D O I：

10.1007/s40278-023-44947-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：106 / 106

相关论文

共 50 条

[1] Cyclophosphamide/rituximabThrombocytopenia and neutropenia: case report
Reactions Weekly, 2021, 1858 (1) : 130 - 130
[2] Cyclophosphamide/docetaxelFebrile neutropenia: case report
Reactions Weekly, 2022, 1911 (1) : 152 - 152
[3] Cyclophosphamide/doxorubicinFebrile neutropenia: case report
Reactions Weekly, 2011, 1342 (1) : 13 - 13
[4] Cyclophosphamide/docetaxelFebrile neutropenia: case report
Reactions Weekly, 2019, 1771 (1) : 112 - 112
[5] Cyclophosphamide/FludarabinePneumonia and neutropenia: case report
Reactions Weekly, 2014, 1531 (1) : 68 - 68
[6] Cyclophosphamide/docetaxelFebrile neutropenia: case report
Reactions Weekly, 2018, 1685 (1) : 70 - 70
[7] Cyclophosphamide/docetaxelFebrile neutropenia: case report
Reactions Weekly, 2016, 1584 (1) : 72 - 72
[8] Cyclophosphamide/paclitaxelFebrile neutropenia: case report
Reactions Weekly, 2020, 1833 (1) : 140 - 140
[9] Cyclophosphamide/vincristineCandidiasis, neutropenia and sepsis: case report
Reactions Weekly, 2016, 1583 (1) : 364 - 364
[10] Cyclophosphamide/dactinomycin/vincristineFebrile neutropenia: case report
Reactions Weekly, 2022, 1921 (1) : 104 - 104

← 1 2 3 4 5 →